The Barbara Ann Karmanos Cancer Institute and the Wayne State University School of Medicine will present a Lung Cancer Symposium on Nov. 11.

Registration for the symposium ends Nov. 9. Register at symposium@karmanos.org.

The cost to attend is $75 for physicians; $50 for retired physicians, pharmacists, mid-level providers, nurses and other allied health providers; and $25 for fellows, residents and medical students refundable upon attendance.

The symposium will take place from 8 a.m. to 3 p.m. at the Westin Southfield, 1500 Town Center, Southfield, Mich.

For additional questions, contact Pamela Sydorchuk at symposium@karmanos.org or 313-576-8746.

Keynote speakers will be Antoinette Wozniak, M.D., FACP, FASCO, adjunct professor of Medicine at the University of Pittsburgh and chief scientific officer of the Lung Cancer Research Foundation; and Taofeek Owonikoko, M.D., Ph.D., division chief and professor of Medicine, Division of Hematology-Oncology, associate director for Translational Research and co-leader of the Cancer Therapeutics Program at the University of Pittsburgh Hilman Cancer Center.

The agenda includes:

7 to 8 a.m.: Registration, breakfast, exhibits

8 to 8:05 a.m.: Welcoming remarks, Hirva Mamdani, M.D., of the Barbara Ann Karmanos Cancer Institute

8:05 to 8:30 a.m.: Biomarker Testing in NSCLC: When and What to Test?, Tarik Hadid, M.D., of the Barbara Ann Karmanos Cancer Institute

8:30 to 9:30 a.m.: Perioperative Systemic Therapy for Resectable NSCLC: Neoadjuvant or Adjuvant or Both?, Antoinette Wozniak, M.D., Lung Cancer Research Foundation

9:30 to 10 a.m.: Surgical Management of Resectable NSCLC in the Era of Immunotherapy and Targeted Therapy, David Sternberg, M.D., Barbara Ann Karmanos Cancer Institute

10 to 10:15 a.m.: Break

10:15 to 10:45: Locally Advanced/Unresectable NSCLC, Greg Durm, M.D., of the Melvin and Bren Simon Comprehensive Cancer Center

10:45 to 11:45 a.m.: Small-cell Lung Cancer: Breakthroughs and Challenges, Taofeek Owonikoko, M.D., Ph.D., of the UPMC Hilman Cancer Center

11:45 to 12:15 p.m.: Treatment of Advanced NSCLC Without Actionable Genomic Alteration, Hirva Mamdani, M.D., of the Barbara Ann Karmanos Cancer Institute

12:15 to 12:45 p.m.: Lunch

12:45 to 1:15 p.m.: Treatment of Advanced NSCLC Harboring EGFR, ALK, ROS1Alterations, Sonam Puri, M.D., of the Huntsman Cancer Institute

1:15 to 1:45 p.m.: Treatment of Advanced NSCLC Harboring KRAS, HER2, RET, MET Alterations, Meera Patel, M.D., M.H.S., of the Dan L. Duncan Comprehensive Cancer Center

1:45 to 2:15 p.m.: Advances in Radiation Therapy for Lung Cancer, Steven Miller, M.D., of the Barbara Ann Karmanos Cancer Institute

2:15 to 2:45 p.m.: Case discussions

2:45 p.m.: Closing remarks